Technologies related to NIDDK

Title
MÍOS: Better Animal Care for Better Research
Ref: E-007-2018/0 | Updated: Nov 21, 2017
Islet Beta Cell Only M3 Muscarinic Acetylcholine Receptor Knockout Mouse
Ref: E-452-2013/0 | Updated: Apr 18, 2017
cGAP-PNA Multivalent Ligand Display at the Nanoscale
Ref: E-761-2013/0 | Updated: Apr 18, 2017
Whole Animal Feeding Flat (WAFFL): A High-throughput Platform for the Automated Handling of Flies
Ref: E-034-2015/0 | Updated: Nov 7, 2017
Transgenic Mice Overexpressing Islet Beta Cell M3 Muscarinic Acetylcholine Receptors
Ref: E-455-2013/0 | Updated: Apr 18, 2017
Alb-tTA (Tg(Alb1-tTA)3123Lng) Mouse Model for Liver Function Studies
Ref: E-125-2012/0 | Updated: Apr 18, 2017
Tg(MMTV-Cre)#Mam Mouse Model for Developmental Biology, Hepatology, and Oncology Studies
Ref: E-113-2012/0 | Updated: Apr 17, 2017
New Cholera Vaccine and Method for Conjugating Bacterial Polysaccharides to Proteins
Ref: E-234-2011/0 | Updated: Jul 12, 2017
MUP-tTA Mouse Model for Liver Function Studies
Ref: E-126-2012/0 | Updated: Apr 17, 2017
M5 Muscarinic Receptor Knockout (Chrm5tm1Jwe) Mouse Model for Neurological Studies
Ref: E-110-2012/0 | Updated: Apr 17, 2017
M3 Muscarinic Receptor Knockout Mice (Chrm3 tm1Jwe) for the Study of Obesity and Other Metabolic Disorders
Ref: E-346-2004/2 | Updated: Apr 17, 2017
Use of Modified Peptide Nucleic Acids for Visualizing DNA
Ref: E-308-2006/3 | Updated: Jul 12, 2017
Transgenic Mice Expressing CNO-sensitive Gq- or Gs-coupled Designer Receptors Selectively in Pancreatic Beta Cells
Ref: E-197-2016/0 | Updated: Apr 17, 2017
A Novel Scaffold for Multivalent Display of Ligands
Ref: E-129-2010/0 | Updated: Apr 17, 2017
The Whey Acidic Protein (WAP) Promoter and Its Use to Express Therapeutic Proteins in the Milk of Transgenic Mammals
Ref: E-411-1987/0 | Updated: Jul 12, 2017
MDCK Cells with Enhanced Characteristics for Vaccine and Virus Production
Ref: E-173-2008/0 | Updated: Jul 12, 2017
Conditional V2 Vasopressin Receptor Mutant Mice as a Model to Study X-linked Nephrogenic Diabetes Insipidus (XNDI)
Ref: E-174-2009/0 | Updated: Jul 12, 2017
Triazole Derivatives of 4,7-disubstituted 2 naphthoic acid (PPTN) as P2Y14 Receptor Antagonists
Ref: E-213-2015-0 | Updated: Sep 6, 2016
Bag6 Polyclonal Antibodies That Recognize Human Bag6 Protein
Ref: E-077-2015/0 | Updated: Sep 8, 2016
Remotely Monitored Mouse Feeding Experimentation Device
Ref: E-209-2015/0 | Updated: Jul 26, 2016
Fetal Hemoglobin Induction for Treating Sickle Cell Disease and Thalassemias
Ref: E-038-2016/0 | Updated: Dec 10, 2015
Autodock Vina Software Process for Efficient Large-Scale Cognate Ligand Screening
Ref: E-289-2014/0 | Updated: Mar 24, 2017
Rabbit Antibody to Mouse Sphingosine-1-phosphate (S1P) lyase
Ref: E-465-2013/0 | Updated: Aug 6, 2013
Rabbit Antibody to Mouse Sphingosine kinase 2 (SphK2)
Ref: E-466-2013/0 | Updated: Aug 6, 2013
Transgenic Mice with Constitutively Active M3 Muscarinic Receptor in Islet Beta Cells
Ref: E-453-2013/0 | Updated: Mar 24, 2017
Modified Peptide Nucleic Acids (PNAs) for Detection of DNA or RNA and Identification of a Disease or Pathogen
Ref: E-260-2012/0 | Updated: Mar 16, 2017
Small Molecule MRS5474 with Anticonvulsant Activity for Treatment of Epilepsy
Ref: E-285-2008/1 | Updated: Aug 31, 2016
Magnetic Resonance Arterial Wall Imaging Methods that Compensate for Patient Aperiodic Intrinsic Cardiac, Chest Wall, and Blood Flow-Induced Motions
Ref: E-185-2012/0 | Updated: Oct 22, 2012
Capillary Viscometer for Measuring Viscosity of Macromolecular Solutions of Biological Relevance
Ref: E-231-2012/0 | Updated: Sep 6, 2016
Polyclonal Antibodies for the Specialized Signaling G protein, Gbeta5
Ref: E-192-2006/0 | Updated: Jul 27, 2012
A3 Adenosine Receptor Agonists to Treat Chemotherapy-induced Peripheral Neuropathy
Ref: E-140-2008/1 | Updated: Jun 13, 2012
Antagonist of A3 Adenosine Receptor Fluorescent Probes for the Study of Diseases that Involve A3 Signaling
Ref: E-073-2012/0 | Updated: Feb 18, 2016
Java Applet for Modeling Human Metabolism and Energy Expenditure for Adaptive Dieting and Exercise Regimens
Ref: E-160-2012/0 | Updated: May 3, 2013
Construct for Tetracycline Inducible Podocyte Specific Gene Expression in Mice
Ref: E-299-2007/0 | Updated: Feb 23, 2016
Sirt1 Knockout (Sirt1tm1.1Cxd) Mouse Model for Oncology and Metabolism Studies
Ref: E-120-2012/0 | Updated: Feb 12, 2015
Sirt6 LoxP (Sirt6tm1.1Cxd) Mouse Model for Liver Studies
Ref: E-121-2012/0 | Updated: Feb 12, 2015
Sirt1 LoxP (Sirt1tm1Cxd) Mouse Model for Metabolism and Hepatology Studies
Ref: E-122-2012/0 | Updated: Feb 12, 2015
Fgfr3 Knockout Mouse Model for Developmental Biology Studies
Ref: E-123-2012/0 | Updated: Apr 19, 2012
Fgfr2 Knockout (Fgfr2tm1Cxd) Mouse Model for Developmental Biology Studies
Ref: E-124-2012/0 | Updated: Feb 12, 2015
mEpoR Knockout/Tg(hEpoR) Mouse Model for Anemia and Renal Function Studies
Ref: E-127-2001/0 | Updated: Feb 12, 2015
Sirt3 Knockout (Sirt3tm1.1Cxd) Mouse Model for Cardiology and Metabolism Studies
Ref: E-119-2012/0 | Updated: Feb 12, 2015
UTX LoxP Mouse Model for Oncology Research
Ref: E-118-2012/0 | Updated: Feb 23, 2016
Smad4 Knockout (Smad4tm1Cxd) Mouse Model for Developmental Biology Studies
Ref: E-133-1999/0 | Updated: Feb 12, 2015
Fgfr4 Knockout Mouse Model for Respiratory System Studies
Ref: E-125-2000/0 | Updated: Feb 12, 2015
Stat1LoxP (Stat1 tm1Mam ) Mouse Model for Oncology and Immunology Studies
Ref: E-111-2012/0 | Updated: Mar 10, 2014
Tg(Wap-cre)11738Mam Mouse Model for Developmental Biology Studies
Ref: E-112-2012/0 | Updated: Apr 19, 2012
Stat5a LoxP/Stat5b LoxP (Stat5a/Stat5btm2Mam) Mouse Model for Mammopoietic and Lactogenic Signaling Studies
Ref: E-114-2012/0 | Updated: Feb 12, 2015
Bcl-x LoxP (Bcl2l1 tm1.1Mam) Mouse Model for Developmental Biology Studies
Ref: E-115-2012/0 | Updated: Mar 10, 2014
Stat5a Knockout (Stat5atm1Mam) Mouse Model for Mammopoietic and Lactogenic Signaling Studies
Ref: E-116-2012/0 | Updated: Feb 12, 2015
Gs Alpha LoxP (Gnastm1Lsw) Mouse Model for Metabolism Studies
Ref: E-117-2012/0 | Updated: Feb 12, 2015
Personalized Body Weight Management System Using Monitoring Devices and Mathematical Models of Metabolism
Ref: E-063-2012/0 | Updated: Mar 23, 2012
Fibroblast Growth Factor Receptor 1 (Fgfr1) Conditional Knock Out Mouse
Ref: E-071-2011/0 | Updated: Dec 2, 2011
Conditionally Immortalized Human Podocyte Cell Lines
Ref: E-252-2010/0 | Updated: Jul 27, 2011
CDK4-Transformed Mouse Podocytes Useful for Studying Glomerular Diseases
Ref: E-287-2010/0 | Updated: Jul 27, 2011
Polyclonal Antibodies for the Gbeta5-associated Regulator of G Protein Signaling Protein, RGS7
Ref: E-077-2011/0 | Updated: Apr 11, 2016
Phantasmidine, a Nicotinic Receptor Agonist for the Treatment of Addiction and Neurological Disorders
Ref: E-125-2010/0 | Updated: Sep 20, 2010
N-Methanocarba Adenosine Derivatives and Their Dendrimer Conjugates as A3 Receptor Agonists
Ref: E-049-2010/2 | Updated: Sep 9, 2013
Software System for Processing and Analysis of Multi-dimensional NMR Data
Ref: E-076-2009/0 | Updated: Sep 10, 2015
Mouse Macula Densa Cell Line
Ref: E-234-2009/0 | Updated: Jan 25, 2010
Truncated Methanocarba Adenosine Derivatives as A3 Adenosine Receptor Antagonists
Ref: E-285-2008/0 | Updated: Sep 8, 2016
Small-Molecule TSH Receptor Modulators for Diagnosis and Treatment of Thyroid Disease and Cancer
Ref: E-223-2006/0 | Updated: Dec 3, 2013
Mice with a Conditional LoxP-Flanked Glucosylceramide Synthase Allele Controlling Glycosphingolipid Synthesis
Ref: E-320-2007/0 | Updated: Jan 1, 2009
Prostatic Adenocarcinoma Cells Expressing or Lacking the Tumor Suppressor Gene PTEN
Ref: E-292-2008/0 | Updated: Oct 1, 2008
Vitamin D Receptor Antagonists for Treating Breast Cancer
Ref: E-213-2001/2 | Updated: Sep 1, 2008
Methods for Preparing Bacillus anthracis Protective Antigen for Use in Vaccines
Ref: E-023-2002/0 | Updated: Sep 1, 2008
Broadly Neutralizing Anti-HIV Monoclonal Antibody That Targets a New Epitope on gp41
Ref: E-229-2008/0 | Updated: Aug 1, 2008
Species-Independent A3 Adenosine Receptor Agonists Which May Be Useful for Treating Ischemia, Controlling Inflammation, and Regulating Cell Proliferation
Ref: E-140-2008/0 | Updated: Sep 24, 2013
Monoclonal Antibodies to HIV-1 Vpr
Ref: E-141-2003/0 | Updated: Aug 1, 2008
Rapid and Sensitive Detection of Nucleic Acid Sequence Variations
Ref: E-071-2003/0 | Updated: Jul 1, 2008
Model for Study of Glomerular Disorders: Conditionally-Immortalized Mouse Podocyte Cell Line with Tet-on-Regulated Gene Expression
Ref: E-049-2007/0 | Updated: Mar 1, 2007
A Nurr1-Knockout Mouse Model for Parkinson's Disease and Stem Cell Differentiation
Ref: E-024-1999/0 | Updated: Aug 31, 2010
Image Guided Systems and Methods for Organ Viability Assessment
Ref: E-098-2005/0 | Updated: Jun 1, 2006
Methods for Rapid and Specific Fluorescent Staining of Biological Tissue for Laser Capture Microdissection
Ref: E-133-2000/0 | Updated: Mar 1, 2006
A Mouse with a Targeted Mutation in the Uncoupling Protein-3 (upc3) Gene
Ref: E-031-1999/0 | Updated: Jun 16, 2010
Chromatin Insulator Protecting Expressed Genes of Interest for Human Gene Therapy or Other Mammalian Transgenic Systems
Ref: E-206-1992/1 | Updated: Mar 1, 2005
HGC-1, A Gene Encoding a Member of the Olfactomedin-Related Protein Family
Ref: E-166-2001/0 | Updated: Mar 1, 2005
Generation of Smad3-null Mice and Smad4-conditional Mice
Ref: E-349-2003/0 | Updated: Jun 16, 2010
A Mouse Model for Type 2 Diabetes
Ref: E-132-2003/0 | Updated: Jun 16, 2010
A Mouse Model for Systemic Inflammation in Glucocerebrosidase-Deficient Mice with Minimal Glucosylceramide Storage
Ref: E-256-2003/0 | Updated: Dec 1, 2003
Methanocarba Cycloalkyl Nucleoside Analogues
Ref: E-176-1999/0 | Updated: May 1, 2003
Fibroblast Growth Factor 3 (FGFR3) Receptor Knockin Mice
Ref: E-060-2003/0 | Updated: Feb 1, 2003
Parallel Measurements of Multiple Macromolecules Using a Cryoarray
Ref: E-064-2001/0 | Updated: Jan 1, 2002
Subscribe to Technologies related to NIDDK